Junqi He
Qingdao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Overexpression of SLC44A4 suppresses ferroptosis and reduces lipid peroxidation via noncanonical NF-κB signaling in a NIK-dependent manner.
Journal: Annals of medicine
Published: May 26, 2026
Target-anchoring nanofibers with retention-enhanced drug delivery for synergistic chemo-photothermal therapy of ovarian cancer.
Journal: Colloids and surfaces. B, Biointerfaces
Published: April 17, 2026
SLC45A4 expression in cancer-associated fibroblasts is associated with epithelial ovarian cancer progression and HIF-1α-glycolysis signaling activation.
Journal: Scientific reports
Published: March 18, 2026
IGF2BP3 promotes epithelial ovarian cancer progression by regulating FASN expression.
Journal: Scientific reports
Published: October 11, 2025
DHCR24 overexpression is involved in lipid metabolic reprogramming to drive cervical cancer malignant progression and is associated with immune microenvironment.
Journal: BMC cancer
Published: June 16, 2025
Uncovering potential targets for antibody-drug conjugates in the treatment of gynecologic malignancies.
Journal: Frontiers in pharmacology
Published: November 10, 2024
Cancer-associated fibroblasts in ovarian cancer: research progress.
Journal: Frontiers in oncology
Published: October 01, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026